Simon Frey

Dr. Simon Frey

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
SBSören Backhaus
Sören Backhaus
TLTorben Lange
Torben Lange
ASAlexander Schulz
Alexander Schulz
RERuben Evertz
Ruben Evertz
SFSimon Frey
Simon Frey
ASAndreas Schuster
Andreas Schuster
Evaluation of the left atrioventricular coupling index (LACI) in a rest and exercise-stress cardiovascular magnetic resonance imaging protocol allows identification of patients with heart failure and preserved ejection fraction with high diagnostic accuracy. LACI holds similar diagnostic accuracy at rest compared with left atrial ejection fraction during exercise stress. This highlights the value of LACI as a widely available and cost-effective test for diastolic dysfunction, which may help to guide patient selection for referral to specialized testing/treatment.

1 June 2022 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
SFSimon Frey
Simon Frey
UHUrsina Honegger
Ursina Honegger
OCOlivier F. Clerc
Olivier F. Clerc
Federico CaobelliFederico Caobelli
Federico Caobelli
PHPhilip Haaf
Philip Haaf
MZMichael J. Zellweger
Michael J. Zellweger

25 April 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TITevfik F. Ismail
Tevfik F. Ismail
SFSimon Frey
Simon Frey
BKBeat Kaufmann
Beat Kaufmann
DWDavid Winkel
David Winkel
DBDaniel T. Boll
Daniel T. Boll
PHPhilip Haaf
Philip Haaf
Hypertensive heart disease (HHD) develops in response to the chronic exposure of the left ventricle and left atrium to elevated systemic blood pressure. Left ventricular structural changes include hypertrophy and interstitial fibrosis that in turn lead to functional changes including diastolic dysfunction and impaired left atrial and LV mechanical function. Ultimately, these changes can lead to heart failure with a preserved (HFpEF) or reduced (HFrEF) ejection fraction. This review will outline the clinical evaluation of a patient with hypertension and/or suspected HHD, with a particular emphasis on the role and recent advances of multimodality imaging in both diagnosis and differential diagnosis.

25 March 2024 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
RCR Crawley
R Crawley
KKK P Kunze
K P Kunze
XMX Milidonis
X Milidonis
JHJ Highton
J Highton
SMS McElroy
S McElroy
ACAmedeo Chiribiri
Amedeo Chiribiri
Current assessment of myocardial ischaemia from stress perfusion cardiovascular magnetic resonance (SP-CMR) largely relies on visual interpretation. This study investigated the use of high-resolution free-breathing SP-CMR with automated quantitative mapping in the diagnosis of coronary artery disease (CAD). Diagnostic performance was evaluated against invasive coronary angiography (ICA) with fractional flow reserve (FFR) measurement. Seven hundred and three patients were recruited for SP-CMR using the research sequence at 3 Tesla. Of those receiving ICA within 6 months, 80 patients had either FFR measurement or identification of a chronic total occlusion (CTO) with inducible perfusion defects seen on SP-CMR. Myocardial blood flow (MBF) maps were automatically generated in-line on the scanner following image acquisition at hyperaemic stress and rest, allowing myocardial perfusion reserve (MPR) calculation. Seventy-five coronary vessels assessed by FFR and 28 vessels with CTO were evaluated at both segmental and coronary territory level. Coronary territory stress MBF and MPR were reduced in FFR-positive (≤0.80) regions [median stress MBF: 1.74 (0.90–2.17) mL/min/g; MPR: 1.67 (1.10–1.89)] compared with FFR-negative regions [stress MBF: 2.50 (2.15–2.95) mL/min/g; MPR 2.35 (2.06–2.54) P < 0.001 for both]. Stress MBF ≤ 1.94 mL/min/g and MPR ≤ 1.97 accurately detected FFR-positive CAD on a per-vessel basis (area under the curve: 0.85 and 0.96, respectively; P < 0.001 for both). A novel scanner-integrated high-resolution free-breathing SP-CMR sequence with automated in-line perfusion mapping is presented which accurately detects functionally significant CAD. High-resolution free-breathing stress perfusion cardiovascular magnetic resonance (SP-CMR) with in-line automated quantitative mapping is accurate in the diagnosis of functionally significant coronary artery disease. Diagnostic performance was compared with invasive fractional flow reserve (FFR) with myocardial blood flow (MBF) at hyperaemic stress and myocardial perfusion reserve (MPR) reduced in patients with inducible ischaemia. CTO, chronic total occlusion; AUC, area under the curve.

1 December 2021 in American Heart Journal
Verified
Journal Article
Closed access
LKLuca Koechlin
Luca Koechlin
JBJasper Boeddinghaus
Jasper Boeddinghaus
TNThomas Nestelberger
Thomas Nestelberger
PAPedro Lopez Ayala
Pedro Lopez Ayala
DWDesiree Wussler
Desiree Wussler
JGJoaquim Gea
Joaquim Gea

29 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MHMatthias Haegele
Matthias Haegele
ADAleksandar Djurdjevic
Aleksandar Djurdjevic
FJFabian Jordan
Fabian Jordan
YLYu-Ching Liu
Yu-Ching Liu
LMLeonie Mildner
Leonie Mildner
OPOtmar Pfister
Otmar Pfister
In 2019 the European Society of Cardiology (ESC) lowered the target values for low-density lipoprotein cholesterol (LDL-C) from <1.8 mmol/L to <1.4 mmol/L for secondary prevention of cardiovascular disease (CVD). The aim of this study was to determine the clinical impact of the 2019 ESC/EAS dyslipidaemia guidelines on lipid-lowering therapies and achievement rates of LDL-C targets in a contemporary cohort of CAD patients participating in an ambulatory cardiac rehabilitation (CR) program.We conducted a retrospective analysis of prospectively collected data from the Swiss Secondary Prevention Registry (SwissPR) in patients with Coronary Artery Disease (CAD), who completed the ambulatory cardiovascular rehabilitation program (CR) of the University Hospital Basel, Switzerland from January 2017 to April 2021. To evaluate the impact of the guideline publication, the cohort was split into a pre-Guideline 2019 group (A) and a post-Guideline 2019 group (B). In total 1320 patients were screened leaving 875 patients for analysis. At discharge, more patients in group B were on maximal statin doses (20% vs. 9%, p < 0.0001) and on combination therapy with ezetimibe (51% vs. 17%, p < 0.0001) than in group A, which resulted in 53% of patients reaching the LDL-C target of 50% of the LDL-C target <1.4 mmol/L in CAD patients participating in ambulatory CR.